The American Cancer Society (ACS) has updated its guideline for HPV vaccination, adapting a 2019 update from the Federal Advisory Committee on Immunization Practices (ACIP). The ACS's update addresses three key issues: The ACS adaptation emphasizes that vaccination may be routinely offered at age 9-12; it endorses harmonization of catch-up vaccination for all individuals through age 26 while continuing to include a qualifying statement about reduced effectiveness of vaccination at older ages (i.e., young adults as compared to teens and pre-teens); and does not endorse the recommendation for shared clinical decision-making about vaccination for adults aged 27-45 years.
|